Table 3 Patient characteristics (N = 51)*
Frecuency N | (%) | ||
|---|---|---|---|
Gender | Female | 19 | 37.3 |
Male | 32 | 62.7 | |
Age (years) | Median (range) | 70 | (31–85) |
Tumor size (cm) | Median (range) | 3.7 | (0.5 - 11) |
Localization | Ascending colon | 21 | 41.2 |
Descending colon | 8 | 15.7 | |
Sigmoid | 22 | 43.1 | |
Differentiation | Well differentiated | 19 | 37.3 |
Moderately differentiated | 28 | 54,9 | |
Poorly differentiated | 4 | 7.8 | |
T | T1 | 3 | 5,9 |
T2 | 7 | 13.7 | |
T3 | 28 | 54.9 | |
T4 | 13 | 25.5 | |
N | pN0 | 25 | 49.0 |
pN1 | 26 | 51.0 | |
M | M0 | 39 | 76.5 |
M1 | 12 | 23.5 | |
TNM staging | I | 8 | 15,7 |
IIA | 12 | 23,5 | |
IIB | 4 | 7,8 | |
IIIA | 1 | 2,0 | |
IIIB | 9 | 17,6 | |
IIIC | 5 | 9,8 | |
IV | 12 | 23,5 | |
Dukes staging | A | 8 | 15,7 |
B | 16 | 31,4 | |
C | 15 | 29,4 | |
D | 12 | 23,5 | |
Anti-procollagen 11A1 immunostaining by score | 0 | 3 | 5.9 |
1 | 12 | 23.5 | |
2 | 13 | 25.5 | |
3 | 4 | 7.8 | |
4 | 6 | 11.8 | |
6 | 13 | 25.5 | |
Anti-procollagen 11A1 immunostaining | Low (≤2) | 28 | 54.9 |
(Median =2) | High (>2) | 23 | 45.1 |